The Cool Down on MSN
Amgen recalls nearly 1 million U.S. bottles of heart drug Corlanor over possible contamination
Tests found that the foreign matter does not pose a clinical risk to patients.
3don MSN
How safe is Amgen's dividend?
Near-term headwinds could sink the stock, but there is more to the story.
Amgen has initiated several product recalls in the US for Sensipar (cinacalcet) and Corlanor (ivabradine). The recalls ...
StockStory.org on MSN
Amgen (AMGN): Buy, sell, or hold post Q1 earnings?
Amgen trades at $365.22 per share and has stayed right on track with the overall market, gaining 12% over the last six months ...
Amgen has resisted that withdrawal push, prompting the FDA to double down in April with a formal proposal to pull the drug ...
Amgen has reacted with consternation to the news that treatment with its KRAS inhibitor Lumykras will no longer be funded in ...
Amgen (AMGN) closed at $366.44 in the latest trading session, marking a -2.06% move from the prior day. The stock's change ...
Amgen has issued a voluntary recall for nearly 1 million bottles of the heart medication Corlanor (ivabradine) due to possible contamination. The nationwide recall was issued by the company on June 4 ...
By Puyaan Singh June 29 (Reuters) - The New England Journal of Medicine on Monday retracted an article on a pivotal clinical ...
Amgen recalls 934K bottles of Corlanor and Sensipar due to foreign material and manufacturing deviations, per FDA June 23 report.
View Amgen Inc. AMGN stock quote prices, financial information, real-time forecasts, and company news from CNN.
By Jonathan Stempel July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results